Advertisement
Screener

BIOLASE, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

BIOLASE, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

BIOLASE, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$10.71 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.

Financial Statements › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2024-11-07

  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$1.43M.
  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$2.80M.
  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$6.49M.
  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$5.33M.
  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$20.63M.
  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$28.63M.
  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$16.16M.
  • BIOLASE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$16.83M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month
2024-09-30-$1.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$4.23M
derived: sum of 2 quarters · filed 2024-11-07
-$10.71M
10-Q · filed 2024-11-07
-$16.04M
derived: sum of 4 quarters · filed 2024-11-07
2024-06-30-$2.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$9.28M
10-Q · filed 2024-08-08
-$14.61M
derived: sum of 3 quarters · filed 2024-08-08
-$19.20M
derived: sum of 4 quarters · filed 2024-11-07
2024-03-31-$6.49M
10-Q · filed 2024-05-13
-$11.81M
derived: sum of 2 quarters · filed 2024-05-13
-$16.40M
derived: sum of 3 quarters · filed 2024-11-07
-$21.27M
derived: sum of 4 quarters · filed 2024-11-07
2023-12-31-$5.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
-$9.91M
derived: sum of 2 quarters · filed 2024-11-07
-$14.78M
derived: sum of 3 quarters · filed 2024-11-07
-$20.63M
10-K · filed 2024-03-21
2023-09-30-$4.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$9.46M
derived: sum of 2 quarters · filed 2024-11-07
-$15.31M
10-Q · filed 2024-11-07
-$25.17M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$4.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$10.72M
10-Q · filed 2024-08-08
-$20.58M
derived: sum of 3 quarters · filed 2024-08-08
-$28.96M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$5.85M
10-Q · filed 2024-05-13
-$15.71M
derived: sum of 2 quarters · filed 2024-05-13
-$24.10M
derived: sum of 3 quarters · filed 2024-05-13
-$29.71M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$9.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
-$18.25M
derived: sum of 2 quarters · filed 2024-03-21
-$23.86M
derived: sum of 3 quarters · filed 2024-03-21
-$28.63M
10-K · filed 2024-03-21
2022-09-30-$8.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$14.00M
derived: sum of 2 quarters · filed 2023-11-09
-$18.77M
10-Q · filed 2023-11-09
-$24.05M
derived: sum of 4 quarters · filed 2024-03-21
2022-06-30-$5.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$10.39M
10-Q · filed 2023-08-10
-$15.66M
derived: sum of 3 quarters · filed 2024-03-21
-$18.94M
derived: sum of 4 quarters · filed 2024-03-21
2022-03-31-$4.78M
10-Q · filed 2023-05-11
-$10.05M
derived: sum of 2 quarters · filed 2024-03-21
-$13.33M
derived: sum of 3 quarters · filed 2024-03-21
-$14.03M
derived: sum of 4 quarters · filed 2024-03-21
2021-12-31-$5.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
-$8.55M
derived: sum of 2 quarters · filed 2024-03-21
-$9.26M
derived: sum of 3 quarters · filed 2024-03-21
-$16.16M
10-K · filed 2024-03-21
2021-09-30-$3.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$3.98M
derived: sum of 2 quarters · filed 2022-11-10
-$10.88M
10-Q · filed 2022-11-10
-$17.02M
derived: sum of 4 quarters · filed 2023-03-28
2021-06-30-$702.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$7.60M
10-Q · filed 2022-08-11
-$13.74M
derived: sum of 3 quarters · filed 2023-03-28
-$13.73M
derived: sum of 4 quarters · filed 2023-03-28
2021-03-31-$6.90M
10-Q · filed 2022-05-12
-$13.04M
derived: sum of 2 quarters · filed 2023-03-28
-$13.03M
derived: sum of 3 quarters · filed 2023-03-28
-$17.72M
derived: sum of 4 quarters · filed 2023-03-28
2020-12-31-$6.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$6.13M
derived: sum of 2 quarters · filed 2023-03-28
-$10.82M
derived: sum of 3 quarters · filed 2023-03-28
-$16.83M
10-K · filed 2023-03-28
2020-09-30$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$4.68M
derived: sum of 2 quarters · filed 2021-11-10
-$10.69M
10-Q · filed 2021-11-10
-$14.27M
derived: sum of 4 quarters · filed 2022-03-17
2020-06-30-$4.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
-$10.70M
10-Q · filed 2021-08-13
-$14.29M
derived: sum of 3 quarters · filed 2022-03-17
-$19.76M
derived: sum of 4 quarters · filed 2022-03-17
2020-03-31-$6.01M
10-Q · filed 2021-05-13
-$9.59M
derived: sum of 2 quarters · filed 2022-03-17
-$15.06M
derived: sum of 3 quarters · filed 2022-03-17
-$18.96M
derived: sum of 4 quarters · filed 2022-03-17
2019-12-31-$3.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
-$9.06M
derived: sum of 2 quarters · filed 2022-03-17
-$12.96M
derived: sum of 3 quarters · filed 2022-03-17
-$17.86M
10-K · filed 2022-03-17
2019-09-30-$5.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
-$9.37M
derived: sum of 2 quarters · filed 2020-11-13
-$14.27M
10-Q · filed 2020-11-13
-$21.19M
derived: sum of 4 quarters · filed 2021-03-31
2019-06-30-$3.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
-$8.80M
10-Q · filed 2020-08-14
-$15.72M
derived: sum of 3 quarters · filed 2021-03-31
-$20.38M
derived: sum of 4 quarters · filed 2021-03-31
2019-03-31-$4.90M
10-Q · filed 2020-05-08
-$11.82M
derived: sum of 2 quarters · filed 2021-03-31
-$16.48M
derived: sum of 3 quarters · filed 2021-03-31
-$21.39M
derived: sum of 4 quarters · filed 2021-03-31
2018-12-31-$6.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$11.58M
derived: sum of 2 quarters · filed 2021-03-31
-$16.50M
derived: sum of 3 quarters · filed 2021-03-31
-$21.52M
10-K · filed 2021-03-31
2018-09-30-$4.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$9.58M
derived: sum of 2 quarters · filed 2019-11-12
-$14.60M
10-Q · filed 2019-11-12
-$18.44M
derived: sum of 4 quarters · filed 2020-03-30
2018-06-30-$4.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$9.93M
10-Q · filed 2019-08-09
-$13.77M
derived: sum of 3 quarters · filed 2020-03-30
2018-03-31-$5.02M
10-Q · filed 2019-05-10
-$8.86M
derived: sum of 2 quarters · filed 2020-03-30
2017-12-31-$3.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$16.85M
10-K · filed 2020-03-30
2017-09-30-$13.01M
10-Q · filed 2018-11-14
2016-12-31-$15.37M
10-K · filed 2019-03-08